Distribution of exogenous [ 125I]-3-iodothyronamine in mouse in vivo: Relationship with trace amine-associated receptors

Journal of Endocrinology

Volumn 213, Issue 3, 2012, Pages 223-230

  Chiellini, Grazia ^a   Erba, Paola ^a   Carnicelli, Vittoria ^a   Manfredi, Chiara ^a   Frascarelli, Sabina ^a   Ghelardoni, Sandra ^a   Mariani, Giuliano ^a   Zucchi, Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE I 125; G PROTEIN COUPLED RECEPTOR; RADIOISOTOPE; TRACE AMINE ASSOCIATED RECEPTOR; TRACE AMINE ASSOCIATED RECEPTOR 1; TRACE AMINE ASSOCIATED RECEPTOR 8; UNCLASSIFIED DRUG; 3 IODOTHYRONAMINE; 3-IODOTHYRONAMINE; RADIOACTIVE IODINE; TAAR8A PROTEIN, MOUSE; TAAR8A PROTEIN, RAT; THYRONINE DERIVATIVE; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG URINE LEVEL; GALLBLADDER; GENE EXPRESSION; IN VIVO STUDY; INTESTINE; ISOTOPE LABELING; KIDNEY; LIVER; MALE; MOUSE; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; STOMACH; TESTIS; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION PROFILING; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; GENE EXPRESSION PROFILING; INJECTIONS, INTRAVENOUS; INTESTINES; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; STOMACH; TESTIS; THYRONINES; TISSUE DISTRIBUTION;

EID: 84864291174     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0055     Document Type: Article

References (28)

1. Barnett SA &Widdowson EM 1965 Organ-weights and body-composition in mice bred for many generations at -3 C. Proceeding of the Royal Society of London. Series B 162 502-516.
2. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS & Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. Journal of Comparative Physiology 178 167-177.
3. Brochmann EJ, Duarte ME, Zaidi HA & Murray SS 2003 Effects of dietary restriction on total body, femoral, and vertebral bone in SENCAR, C57BL/6, and DBA/2 mice. Metabolism 52 1265-1273.
4. Brown-Grant K 1961 Extrathyroidal iodide concentrating mechanisms. Physiological Reviews 41 189-213.
5. Carnicelli V, Santoro A, Sellari Francechini S, Berrettini S & Zucchi R 2010 Expression of trace amine-associated receptors in human nasal mucosa. Chemosensory Perception 3 99-107.
6. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK et al. 2007 Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB Journal 21 1597-1608.
7. Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G & Zucchi R 2012 Detection of 3-iodothyronamine in human patients: a preliminary study. Journal of Clinical Endocrinology and Metabolism 97 E69-E74.
8. Grandy DK 2007 Trace amine-associated receptor 1 - family archetype or iconoclast? Pharmacology & Therapeutics 116 355-390
9. Griffin GE & Goldspink G 1973 The increase in skeletal muscle mass in male and female mice. Anatomical Record 177 465-470.
10. Hoefig CS, Koehrle J, Brabant G, Dixit K, Yap B, Strasburger CJ & Wu Z 2011 Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. Journal of Clinical Endocrinology and Metabolism 96 1864-1872.
11. 1AM): a new chapter of thyroid hormone endocrinology? Molecular BioSystems 6 1338-1344
12. Ianculescu AG, Friesema EC, Visser TJ, Giacomini KM & Scanlan TS 2010 Transport of thyroid hormones is selectively inibited by 3-iodothyronamine. Molecular BioSystems 6 1403-1410.
13. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E & Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. Journal of Endocrinology 201 377-386.
14. Liberles SD 2009 Trace amine-associated receptors are olfactory receptors in vertebrates. International Symposium on Olfaction and Taste. Annals of the New York Academy of Sciences 1170 168-172.
15. Liberles SD & Buck LB 2006 A second class of chemosensory receptors in the olfactory epithelium. Nature 442 645-650.
16. 1AM). Synthetic Communications 36 891-902.
17. Orsi G, Frascarelli S, Zucchi R & Vozzi G 2011 LT1 models for 3-iodothyronamine time dynamics: a multiscale view. IEEE Transactions on Bio-Medical Engineering 58 3513-3517.
18. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B & Köhrle J 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149 3037-3045.
19. Piehl S, Hoefig C, Scanlan TS & Köhrle J 2011 Thyronamines - past, present, and future. Endocrine Reviews 32 64-80.
20. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M & Coughlin SR 2007 Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. Journal of Clinical Investigation 117 4034-4043.
21. Roy G, Placzek E & Scanlan TS 2012 ApoB-100 containing lipoproteins are the major carriers of 3-iodothyronamine in circulation. Journal of Biological Chemistry 287 1790-1800.
22. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS & Zucchi R 2010 Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151 5063-5073.
23. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S et al. 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature 10 638-642.
24. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards MH & Scanlan TS 2007 Thyronamines inhibit plasma membrane and vescicular monoamine transport. ACS Chemical Biology 2 390-398.
25. Venditti P, Napolitano G, Di Stefano L, Chiellini G, Zucchi R, Scanlan TS & Di Meo S 2011 Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity. Molecular and Cellular Endocrinology 341 55-62.
26. Wood WJL, Geraci T, Nilsen A, DeBarber A & Scanlan TS 2009 Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo. Chembiochem: a European Journal of Chemical Biology 26 361-365.
27. Zucchi R, Chiellini G, Scanlan TS & Grandy DK 2006 Trace amineassociated receptors and their ligands. British Journal of Pharmacology 149 967-978.
28. Zucchi R, Ghelardoni S & Chiellini G 2010 Cardiac effects of thyronamines. Heart Failure Reviews 15 171-176.